Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation

NCT00785902 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT00785902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00785902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation
Lead sponsor
AtriCure, Inc.
Phase
Phase 3
Overall status
Withdrawn
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation